Not independent
Tenure on this board
0.7 yrs
Meeting calendar
BLLN · Annual meeting · Wednesday, June 10, 2026
Billiontoone Inc
2 nominees · 2 ballot items.
Elect two Class I directors (Oguzhan Atay and Akshay Rai) to serve until 2029; and ratify PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.
Market cap
$5.9B
1Y TSR
—
Board grade
D
Record date
Apr 17, 2026
Filing
DEF 14A
Meeting concluded · Jun 10, 2026
Follow how the vote landed and what changed on Billiontoone Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot2
- 1
Election of Directors (Class I) — Oguzhan Atay and Akshay Rai
ManagementBoard: FORElect the two directors named (Oguzhan Atay and Akshay Rai) to serve as Class I directors until the 2029 annual meeting.
- 2
Ratification of Appointment of Independent Registered Public Accounting Firm (PricewaterhouseCoopers LLP
ManagementBoard: FORRatify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.
Director elections
Nominees on the ballot2
Independent
Tenure on this board
0.7 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | ADAMS STREET PARTNERS LLC | 3.7% | 1,711,430 | $135M |
| 2 | Civilization Ventures Management, LLC | 2.4% | 1,099,431 | $87M |
| 3 | BAMCO INC /NY/ | 1.6% | 741,485 | $59M |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.6% | 732,145 | $58M |
| 5 | BAILLIE GIFFORD CO | 1.6% | 720,395 | $57M |
| 6 | Neuberger Berman Group LLC | 1.5% | 709,214 | $38M |
| 7 | NVP Associates, LLC | 1.1% | 513,330 | $41M |
| 8 | Invesco Ltd. | 0.9% | 406,512 | $32M |
| 9 | BAILLIE GIFFORD CO | 0.8% | 375,742 | $30M |
| 10 | WASATCH ADVISORS LP | 0.8% | 369,638 | $29M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Billiontoone Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Amneal Pharmaceuticals IncAMRX
Special meeting·Jul 31, 2026·$5.8B
Doximity IncDOCS
Annual meeting·Aug 27, 2026·$4.1B
Haemonetics CorpHAE
Annual meeting·Jul 24, 2026·$3.6B
Organon & CoOGN
Special meeting·Jul 23, 2026·$3.5B
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.4B
Apogee Therapeutics IncAPGE
Special meeting·Aug 11, 2026·$10.1B
Reference
Frequently asked questions
- When is the Billiontoone Inc 2026 annual meeting?
- Billiontoone Inc (BLLN) holds its 2026 annual shareholder meeting on Wednesday, June 10, 2026.
- What is the record date for the Billiontoone Inc 2026 meeting?
- The record date for the Billiontoone Inc 2026 meeting is Friday, April 17, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Billiontoone Inc's 2026 meeting?
- The board is presenting 2 director nominees at the Billiontoone Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Billiontoone Inc 2026 meeting?
- Shareholders will vote on 2 proposals at the Billiontoone Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.